Novavax, Inc., a biotechnology company that develops next-generation vaccines for serious infectious diseases, announced that it has closed an advance purchase agreement ( APA) with Gavi, the Vaccine Alliance (Gavi) for the supply of its recombinant protein-based COVID-19 vaccine candidate to the COVAX Facility. Under the APA, Novavax is expected to produce and distribute 350…
CEPI, the Coalition for Epidemic Preparedness Innovations, announced that it has entered into a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of a Chikungunya vaccine. CEPI will provide the consortium with up to US$14.1 million for vaccine manufacturing and clinical development of…